BioWorld Asia

Sep. 12, 2007

View Archived Issues

Swedish Study Finds Molecular Cause For Kidney Infections

Aptuit Paying $64M For Evotec Chemistry Unit

Antisoma's Lung Cancer Drug Repeats Strong Phase II Results

Biotech Fears Tough Restrictions From EU On Use of Primates

Nanobody Alliance With BI Could Net €200M For Ablynx

No Abstract Read More

FDA OKs TopoTarget's Totect For Extravasation Treatment

Other News To Note

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Business and Academia Merge In UK-Australia Partnership

UK Opens Door to Work With Hybrid Embryos

LONDON - The UK regulator has agreed to the generation of human/animal hybrid embryos for stem cell research, paving the way for it to consider two applications for licenses to conduct such research. (BioWorld International) Read More

MediGene Gets $21M In Private Share Placement

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...